21-159
Showing 1 - 25 of 6,708
Proenkephalin A and Kidney Replacement Therapy
Suspended
- Acute Kidney Injury
- None planned
-
Gießen, Hessen, GermanyUniversity Hospital Gießen and Marburg
Jan 23, 2023
Severe Hypertriglyceridemia Trial in Worldwide (K-877, Fenofibrate, Placebo (for K-877))
Neurofibromatosis 1, Plexiform Neurofibroma, NF1 Trial (Test group (Group A): FCN-159 8 mg, orally, once daily;, Control group
Not yet recruiting
- Neurofibromatosis 1
- +2 more
- Test group (Group A): FCN-159 8 mg, orally, once daily;
- Control group (Group B): Placebo, orally, once daily;
- (no location specified)
Jun 16, 2023
Capabilities of Perinatal Healthcare Institutions in Federation
Completed
- Prenatal Care
- Referral to Centre of Higher Organizational Level
-
Tešanj, Bosnia and HerzegovinaGeneral Hospital Tešanj
Sep 15, 2023
Down's Syndrome, Fine Motor Skills Trial in Lahore (Self-help skills, Virtual video reality gaming)
Recruiting
- Down's Syndrome
- Fine Motor Skills
- Self-help skills
- Virtual video reality gaming
-
Lahore, Punjab, PakistanRising sun school for special children
Sep 5, 2022
Health Volunteer Trial in Shenzhen (JS002)
Not yet recruiting
- Health Volunteer
-
Shenzhen, Guangdong, ChinaShenzhen Third People's Hospital
May 15, 2023
Advanced Solid Tumor, Gynecologic Cancer, Breast Cancer Trial in United States (PY159 Single agent dose level 1, PY159 Single
Recruiting
- Advanced Solid Tumor
- +7 more
- PY159 Single agent dose level 1
- +17 more
-
San Francisco, California
- +11 more
Nov 3, 2022
Renal Cell Carcinoma Trial in Worldwide (Cabozantinib, Nivolumab, Ipilimumab)
Active, not recruiting
- Renal Cell Carcinoma
- Cabozantinib
- +3 more
-
La Jolla, California
- +159 more
Jan 23, 2023
Hypertension Trial in Lahore (mild aerobic exercise, moderate aerobic exercise)
Completed
- Hypertension
- mild aerobic exercise
- moderate aerobic exercise
-
Lahore, Punjab, PakistanRiphah Rehabilitation Center
Dec 7, 2022
Safety of 50 ug of ChulaCov19-BNA159 mRNA Vaccine, Tolerability of 50 ug of ChulaCov19-BNA159 mRNA Vaccine, Immune Response of
Not yet recruiting
- Safety of 25 ug of ChulaCov19-BNA159 mRNA Vaccine
- +6 more
- ChulaCov19 BNA159 mRNA vaccine
-
Bangkok, Thailand
- +1 more
Nov 30, 2022
Axial Spondyloarthritis, Nonradiographic Axial Spondyloarthritis, Nr-axSpA Trial in Worldwide (Certolizumab Pegol, Placebo)
Completed
- Axial Spondyloarthritis
- +2 more
- Certolizumab Pegol
- Placebo
-
Birmingham, Alabama
- +104 more
Aug 16, 2022
Corona Virus Infection Trial in Worldwide (Sarilumab SAR153191, Placebo)
Completed
- Corona Virus Infection
- Sarilumab SAR153191
- Placebo
-
Caba, Argentina
- +46 more
Mar 15, 2022
Bone Fracture, Humerus Fracture, Surgery Trial (Physiotherapy, Photobiomodulation, Simulation of photobiomodulation)
Not yet recruiting
- Bone Fracture
- +2 more
- Physiotherapy
- +2 more
- (no location specified)
Oct 28, 2023
Gonadotropin-releasing Hormone Agonist in Ovarian Preservation
Recruiting
- Systemic Lupus Erythematosus (Sle)
- Primary Ovarian Insufficiency (Poi)
-
Bethesda, MarylandNational Institute of Arthritis and Musculoskeletal and Skin Dis
Feb 2, 2023
Pain Management Trial in Baghdad (Non-pharmacological pain management strategies)
Completed
- Pain Management
- Non-pharmacological pain management strategies
-
Baghdad, IraqCollege of Nursing- The University of Baghdad
Jul 12, 2023
Head and Neck Squamous Cell Carcinoma, Oral Cancer Trial in Guangzhou (Tirelizumab ,+Carboplatin+albumin-bound paclitaxel)
Recruiting
- Head and Neck Squamous Cell Carcinoma
- Oral Cancer
- Tirelizumab ,+Carboplatin+albumin-bound paclitaxel
-
Guangzhou, Guangdong, ChinaSun yat-sun memorial hospital
Jul 10, 2023
Labor Pain, Labor Fast, Satisfaction, Patient Trial in Istanbul (Birth ball, Squatting)
Completed
- Labor Pain
- +2 more
- Birth ball
- Squatting
-
Istanbul, TurkeyIstanbul University-Cerrahpasa
Jul 26, 2022
Paternal Age and Fetal Aneuploidy
Active, not recruiting
- Trisomy 21
- Optimo prenatal screening test
-
Montréal, Quebec, CanadaClinique Ovo
Aug 7, 2023
Interobserver Variability Desmoplasia
Active, not recruiting
- Cutaneous Squamous Cell Carcinoma
- +3 more
- Assessment by dermatopathologists
-
Maastricht, NetherlandsMaastricht University Medical Center+
Aug 29, 2023